Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT05715320 · COMPLETED
Trial details
- NCT number
- NCT05715320
- Sponsor
- Keymed Biosciences Co.Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-10
- Primary completion
- 2024-07-18
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.